Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01216722 · ClinicalTrials.gov registry record · NA

Study of Resistance Strengthening Versus Ambulation Post-Liver Transplant

A NA study of Liver Transplantation and Resistance Training, sponsored by University of Miami.

Completed
Registry status
NA
Development phase
52
Enrollment target
1
Study location

NCT01216722: Completed NA study of Liver Transplantation and Resistance Training, sponsored by University of Miami.

NCT01216722 is a NA study of Liver Transplantation and Resistance Training that has completed, run by University of Miami. The registered enrollment target is 52 participants, below the 319-participant average among 12 other Liver Transplantation trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01216722, a NA study of Liver Transplantation and Resistance Training, has completed, sponsored by University of Miami.

COMPLETED
Registry status
NA
Development phase
52 participants
Enrollment target
1
Study location

Study Summary

Resistance strengthening exercise will increase strength and functional activity greater than ambulation in subjects post-liver transplantation.

Interventions

  • OTHER Resistance Strengthening Exercise Program

Study Locations (1)

Florida

  • University of Miami Department of Physical Therapy - Coral Gables

Trial Details

FieldValue
Enrollment Target 52 participants
Start Date 2007-10
Est. Completion 2010-07
Phase NA
University of Miami

721 total trials

What the finished NCT01216722 record still lists

NCT01216722 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 52 participants, a relatively small participant target, below the 319-participant average among 12 other Liver Transplantation trials with a reported enrollment target (84% lower).

The record links to 3 conditions, with Liver Transplantation appearing as the primary indexed condition, and to 1 intervention - of which Resistance Strengthening Exercise Program is the first listed.

NCT01216722 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT01216722 about?

NCT01216722 is a clinical study titled "Study of Resistance Strengthening Versus Ambulation Post-Liver Transplant". Resistance strengthening exercise will increase strength and functional activity greater than ambulation in subjects post-liver transplantation.

What is the current status of trial NCT01216722?

This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2007-10. Estimated completion is 2010-07.

What conditions does trial NCT01216722 study?

This clinical trial studies the following conditions: Liver Transplantation, Resistance Training, Activities of Daily Living.

What interventions are being tested in trial NCT01216722?

The interventions under investigation include: Resistance Strengthening Exercise Program (OTHER).

Who is sponsoring clinical trial NCT01216722?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01216722 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Liver Transplantation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01216722's enrollment target sits among peer trials

52 9th of 12 higher than 4 of 12 other Liver Transplantation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Liver Transplantation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02630121 · 52 participants · Phase 4

    Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea

  • NCT03629171 · 52 participants · Phase 2

    Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia

  • NCT04128748 · 52 participants · Phase 1

    Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome

  • NCT04150497 · 52 participants · Phase 1

    Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01216722, the US trial registry maintained by the National Library of Medicine. NCT01216722 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.